{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T19:01:13Z","timestamp":1785006073510,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.eimce.2024.06.001","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T20:01:28Z","timestamp":1718740888000},"page":"133-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pre-exposure prophylaxis program in the Community of Madrid: Two years of experience"],"prefix":"10.1016","volume":"43","author":[{"given":"Nuria","family":"Fern\u00e1ndez Pi\u00f1eiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Ayerdi Aguirrebengoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Orviz Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Gonz\u00e1lez P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Vera Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Puerta L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Rodr\u00edguez Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Lejarraga Ca\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Perez Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"Baza Caraciolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monserrat","family":"Gonz\u00e1lez Polo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florentina","family":"Alcudia P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ruiz Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natividad","family":"Jerez Zamora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Morales Irala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"L\u00f3pez Centeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Alioto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Manuel","family":"Mart\u00ednez Sesmero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Estrada P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Teresa","family":"Ben\u00edtez Gimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge del","family":"Romero Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimce.2024.06.001_bib0005","series-title":"Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.eimce.2024.06.001_bib0010","series-title":"Evidence brief: pre-exposure prophylaxis for HIV prevention in Europe","author":"European Centre for Disease Prevention and Control","year":"2016"},{"key":"10.1016\/j.eimce.2024.06.001_bib0015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/QAI.0b013e31828ece33","article-title":"Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States","volume":"64","author":"Grohskopf","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimce.2024.06.001_bib0020","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"iPrEx Study Team. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimce.2024.06.001_bib0025","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","article-title":"Bangkok Tenofovir Study Group. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"381","author":"Choopanya","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.eimce.2024.06.001_bib0030","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Partners PrEP Study Team. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women","volume":"367","author":"Baeten","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimce.2024.06.001_bib0035","unstructured":"FDA approves drug for HIV prevention. Cdc.gov. 2019 [Accessed 22 October 2023]. Available from: https:\/\/www.cdc.gov\/nchhstp\/newsroom\/2012\/fda-approvesdrugstatement.html."},{"key":"10.1016\/j.eimce.2024.06.001_bib0040","unstructured":"Centers for Disease Control and Prevention: US Public Health Service: Preexposure prophylaxis for the prevention of HIV infection in the United States\u20142021 Update: a clinical practice guideline. [Accessed 22 October 2023]. Available from: https:\/\/www.cdc.gov\/hiv\/pdf\/risk\/prep\/cdc-hiv-prep-guidelines-2021.pdf."},{"key":"10.1016\/j.eimce.2024.06.001_bib0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","article-title":"Pre-exposure prophylaxis to prevent the acqui9sition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial","volume":"387","author":"McCormack","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.eimce.2024.06.001_bib0050","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","article-title":"ANRS IPERGAY Study Group. On-demand preexposure prophylaxis in men at high risk for HIV-1 Infection","volume":"373","author":"Molina","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimce.2024.06.001_bib0055","doi-asserted-by":"crossref","first-page":"112re4","DOI":"10.1126\/scitranslmed.3003174","article-title":"Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission","volume":"3","author":"Patterson","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.eimce.2024.06.001_bib0060","series-title":"La FDA aprueba un segundo medicamento para prevenir las infecciones de VIH como parte de sus esfuerzos continuos para poner fin a la epidemia de VIH [Internet]. U.S. Food and Drug Administration. FDA","year":"2020"},{"key":"10.1016\/j.eimce.2024.06.001_bib0065","author":"EMA"},{"key":"10.1016\/j.eimce.2024.06.001_bib0070","unstructured":"Grupo de Trabajo de PrEP. Plan Nacional sobre el Sida. Ministerio de Sanidad. Manual de implementaci\u00f3n de un Programa de Profilaxis Preexposici\u00f3n al VIH en Espa\u00f1a. Febrero 2020."},{"key":"10.1016\/j.eimce.2024.06.001_bib0075","unstructured":"Grupo de Trabajo de PrEP. Divisi\u00f3n de Control de VIH, ITS, Hepatitis virales y Tuberculosis. Ministerio de Sanidad. Manual de implementaci\u00f3n de un Programa de Profilaxis Preexposici\u00f3n al VIH en Espa\u00f1a. Actualizaci\u00f3n diciembre de 2021."},{"key":"10.1016\/j.eimce.2024.06.001_bib0080","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.eimc.2016.06.006","article-title":"To whom is HIV pre-exposure prophylaxis proposed?","volume":"35","author":"Ayerdi-Aguirrebengoa","year":"2017","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimce.2024.06.001_bib0085","unstructured":"Procedimiento Programa de Profilaxis Preexposici\u00f3n (PrEP) al VIH en adultos y adolescentes. Comunidad.madrid. [Accessed 5 January 2023]. Available from: https:\/\/www.comunidad.madrid\/sites\/default\/files\/doc\/sanidad\/hosp\/documento_prep_cm_definitivo_mayo2022.pdf."},{"key":"10.1016\/j.eimce.2024.06.001_bib0090","doi-asserted-by":"crossref","first-page":"e502","DOI":"10.1016\/S2352-3018(21)00127-2","article-title":"Adoption of guidelines onand use of oral pre-exposure prophylaxis: a global summary and forecasting study. Schaefer, Robin et al.","volume":"8","author":"Schaefer","year":"2021","journal-title":"Lancet HIV"},{"key":"10.1016\/j.eimce.2024.06.001_bib0095","author":"Bourne"},{"key":"10.1016\/j.eimce.2024.06.001_bib0100","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-067261","article-title":"Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort","volume":"12","author":"Nozza","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.eimce.2024.06.001_bib0105","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1093\/jac\/dkab263","article-title":"PrEP monitoring and HIV incidence after PrEP initiation in France: 2016\u201318 nationwide cohort study","volume":"76","author":"Tassi","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimce.2024.06.001_bib0110","article-title":"Experiencia de un programa de profilaxis preexposici\u00f3n en una unidad de virus de la inmunodeficiencia humana hospitalaria. Descripci\u00f3n del perfil basal del usuario e identificaci\u00f3n de oportunidades de mejora","author":"Laguno","year":"2021","journal-title":"Enferm Infecc Microbiol Cl\u00edn"},{"key":"10.1016\/j.eimce.2024.06.001_bib0115","unstructured":"Unidad de vigilancia de VIH, ITS y hepatitis. Vigilancia Epidemiol\u00f3gica del VIH y sida en Espa\u00f1a 2022: Sistema de Informaci\u00f3n sobre Nuevos Diagn\u00f3sticos de VIH y Registro Nacional de Casos de Sida. Centro Nacional de Epidemiolog\u00eda. Instituto de Salud Carlos III\/ Divisi\u00f3n de control de VIH, ITS, Hepatitis virales y tuberculosis. Ministerio de Sanidad. Madrid; noviembre 2023."},{"key":"10.1016\/j.eimce.2024.06.001_bib0120","unstructured":"Europa.eu. [Accessed 27 March 2024]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/truvada-epar-product-information_en.pdf."},{"key":"10.1016\/j.eimce.2024.06.001_bib0125","doi-asserted-by":"crossref","first-page":"e554","DOI":"10.1016\/S2352-3018(22)00133-3","article-title":"ANRS PREVENIR Study Group. Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study","volume":"9","author":"Molina","year":"2022","journal-title":"Lancet HIV"},{"key":"10.1016\/j.eimce.2024.06.001_bib0130","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25953","article-title":"PrEP user profiles, dynamics of PrEP use and follow-up: a cohort analysis at a Belgian HIV centre (2017-2020)","volume":"25","author":"Rotsaert","year":"2022","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.eimce.2024.06.001_bib0135","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25105","article-title":"Amsterdam PrEP Project team in the HIV Transmission Elimination AMsterdam Initiative. Men who have sex with men more often chose daily than event-driven use of pre-exposure prophylaxis: baseline analysis of a demonstration study in Amsterdam","volume":"21","author":"Hoornenborg","year":"2018","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.eimce.2024.06.001_bib0140","unstructured":"Divisi\u00f3n de Control de VIH, ITS, Hepatitis virales y Tuberculosis. Sistema de informaci\u00f3n de programas de Profilaxis Pre-exposici\u00f3n al VIH en Espa\u00f1a (SIPrEP). Informe de resultados noviembre 2019-mayo 2023. Ministerio de Sanidad, julio 2023."},{"key":"10.1016\/j.eimce.2024.06.001_bib0145","article-title":"Incidencia de infecciones de transmisi\u00f3n sexual y modelos de cribado entre usuarios de profilaxis preexposici\u00f3n frente al VIH","author":"Ayerdi","year":"2014","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimce.2024.06.001_bib0150","doi-asserted-by":"crossref","first-page":"159","DOI":"10.7334\/psicothema2022.230","article-title":"Pre-exposure prophylaxis, anxiety, depression and sexual satisfactionamong men who have sex with men","volume":"35","author":"Reiriz","year":"2023","journal-title":"Psicothema"}],"container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X24001473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X24001473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T10:14:31Z","timestamp":1740910471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2529993X24001473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2529993X24001473"],"URL":"https:\/\/doi.org\/10.1016\/j.eimce.2024.06.001","relation":{},"ISSN":["2529-993X"],"issn-type":[{"value":"2529-993X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-exposure prophylaxis program in the Community of Madrid: Two years of experience","name":"articletitle","label":"Article Title"},{"value":"Enfermedades infecciosas y microbiologia clinica (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimce.2024.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2024.03.014","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica.","name":"copyright","label":"Copyright"}]}}